Pelvic venous insufficiency — an often-forgotten cause of chronic pelvic pain by Szymanski, Jacek et al.
704
RE VIE W PAPER /  G y n E co lo G y
Ginekologia Polska
2020, vol. 91, no. 11, 704–708




Jacek Szymanski, First Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, 90 Żelazna St, 01–004 Warsaw, Poland 
phone: +48 601 243 792, e-mail: j.szymanski@szpitalzelazna.pl
Pelvic venous insufficiency — an often-forgotten  
cause of chronic pelvic pain
Jacek Szymanski , Grzegorz Jakiel , Aneta Slabuszewska-Jozwiak
1st Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, Warsaw, Poland
AbStrAct
Chronic pelvic pain is a common health problem that afflicts 39% of women at some time in their life. It is a common challenge 
for gynecologists, internists, surgeons, gastroenterologists, and pain management physicians. Pelvic venous insufficiency 
(PVI) accounts for 16–31% of cases of chronic pain but it seems to be often overlooked in differential diagnosis. The aim of 
this article was to summarize current data concerning PVI. The embolization of insufficient ovarian veins remains the gold 
standard of therapy but the optimal procedure is yet to be determined. Well-designed randomized trials are required to 
establish the best treatment modalities.
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The term chronic pelvic pain (CPP) refers to a pain syn-
drome experienced by women that lasts more than six 
months and negatively impacts their everyday activities 
to a high degree, decreasing their quality of life. The pain is 
hardly associated with the menstrual cycle and pregnancy 
but can be exacerbated by some hormonal or behavioral 
conditions (sexual intercourse). The origin of this bother-
some syndrome is related to a variety of pathologies. CPP 
afflicts millions of women worldwide and often requires 
a multi-specialization medical approach in the diagnostic 
and therapeutic process. The incidence of CPP in the UK 
is estimated to be 38/1,0000 patients per year [1]. Since 
the diagnosis of chronic pelvic pain still remains a chal-
lenge, one third of the patients who are evaluated yield 
no clear etiology. Subsequently, one third of those with 
no apparent cause of pelvic pain have pelvic venous insuf-
ficiency (PVI). Two definitions related to this condition are 
often mixed and covered by the term CPP. Pelvic (venous) 
congestion syndrome (PCS) refers to chronic pelvic pain 
resulting from pelvic venous distention. However, due to 
the lack of detailed diagnostic criteria, PCS should not be 
a recognized entity. Some data suggest that CPP could 
be secondary to PVI, with clinical manifestations of pelvic 
and vulvar discomfort, dyspareunia as well as lower back 
pain. The symptoms usually potentiate in the evening and 
often release in a supine position [2]. The pathophysiology 
of PVI is related to retrograde flow through incompetent 
gonadal and pelvic veins. This pathology can result from 
primary vulvar insufficiency, venous outflow obstruction, 
and hormonally mediated vasomotor dysfunction. The term 
PVI should be preferred as it seems to be the closest to the 
pathological background of this condition [3].
The problem affects women of childbearing age, sug-
gesting its relation to hormonal status. Animal studies have 
shown ovarian vain distention when exposed to increased 
doses of estrogens. Furthermore, the exacerbation of signs 
and symptoms is demonstrated during pregnancy and the 
menstrual cycle with relief from pain occurring after the 
menopause [4]. Multiparity seems to be a risk factor for PVI. 
Vein capacity during pregnancy can increase by as much as 
60%. Additionally, the anatomical changes in the pelvis and 
increase in weight during pregnancy may result in tempo-
rary venous obstruction [5]. From a mechanical point of view, 
venous dilatation could result from incompetent valves and 
retrograde venous flow. The venous system of the pelvis 
builds an anastomotic plexus with the main direction of the 
blood flow going from the uterus, parametrium, and meso-
salpinx to the internal iliac and ovarian veins [6]. In typical 
anatomic conditions, the left ovarian vein drains to the left 
renal vein and the vena cava receives the right ovarian vein. 
Anatomical variabilities may cause an obstruction of the 
blood flow leading to venal dilatation and insufficiency. 
Additionally, compression of the left ovarian vein by the 
superior mesenteric artery may occur (nutcracker phenom-
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enon) and the left iliac vein may be compressed against the 
lumbar vertebral bodies by the right common iliac artery, 
which could result in endothelial damage, thickening, and 
venous congestion (May-Thurner syndrome) [5, 7]. Imaging 
studies have shown that an ovarian vein diameter greater 
than 8 mm is associated with significantly wider peri-uterine 
veins compared to a diameter less than 8 mm [3]. In general, 
two physiopathological mechanisms underlie this condition:
1. Venous outflow obstruction impeding the centripetal 
direction of flow.
2. Venous vulvar dysfunction and venous leakage through 
collateral routes, permitting flow reentry in a centrifugal 
(proximal-to-distal) direction [8].
One of the classifications of pelvic varicose veins distin-
guishes three types of vein damage:
1. Vascular wall pathology (valvular incompetence, mal-
formations or agenesis);
2. Vascular compression effects such as the nutcracker 
syndrome or the May-Thurner syndrome; and
3. Pathology-induced (e.g., endometriosis or pelvic tumor) 
local extrinsic compression [6].
Pelvic congestion syndrome is usually related to incom-
petent internal pudendal and broad ligament parametrial 
branches, whilst vulvar and lower limb varicosities refer 
to incompetent branches of the circumflex femoral and 
obturator veins [9].
clinicAl PreSentAtion
Most women suffer from prolonged noncyclical pelvic 
pain accompanied by dyspareunia and post-coital discom-
fort, bladder irritation, and dysmenorrhea. The pain may 
increase while sitting, standing, at the end of the day, or 
just before the onset of the menses. Additionally, vaginal 
discharge, vulvar edema, and tenderness of the pelvis that 
may contribute to depression could also be present. Vulvar 
varicosities and varicose veins on the posterior surfaces of 
the thighs may be found in physical examination. A gyneco-
logical examination often reveals uterine dyskinesia and 
palpatory tenderness over the ovaries. Moreover, varices of 
the vulva, vagina, and in perianal area are often identified. 
One in five women presenting with varicose veins have 
reflux of non-saphenous origin, with the associated pelvic 
vein reflux present in one in six [10]. The differential diag-
nosis should include endometriosis, pelvic inflammatory 
disease (PID), ovarian tumors, bowel pathology, fibroids, 
pelvic organ prolapse, urologic pathology, and porphyria 
[5, 6]. A case of PCS initially misdiagnosed as a hydrosalpinx 
was also reported [11].
DiAGnoSiS
Pelvic ultrasound (US) is typically the first-line imaging 
modality in the diagnostic process of patients with chronic 
pelvic pain. The advantage of a Doppler ultrasound exami-
nation is the ability to provide information about venous 
blood flow. Beard et al. have established criteria for the 
sonographic diagnosis of pelvic varices:
1. Visualization of the ovarian veins dilated above 4 mm 
in diameter,
2. Communication of the dilated tortuous arcuate veins 
in the myometrium with bilateral pelvic varicose veins,
3. Blood flow less than 3 cm/s, and
4. Detection of retrograde venous blood flow in the left 
ovarian vein [12].
The dilatation of pelvic veins > 8 mm is associated with 
reflux and symptoms, while the diameter 4–8 mm is usu-
ally related to asymptomatic reflux [13]. In contrary, Dos 
Santos et al. showed no significant difference between the 
diameters of competent and refluxing ovarian veins, con-
cluding that it is not acceptable to use vein diameter as 
an indicator of ovarian venous reflux [14]. Park et al. [15], 
with a combination of transabdominal and transvaginal 
Doppler ultrasound in the evaluation of women with CPP 
and PVI, found that the mean left ovarian vein diameter was 
greater in symptomatic patients as compared to healthy 
controls (0.79 vs 0.49 cm, p < 0.001). Furthermore, the au-
thors reported a sensitivity of 100% and specificity of 75% 
when evaluating retrograde flow in gonadal veins with 
the use of transabdominal ultrasound. In another study, 
the sensitivity and specificity of duplex ultrasound for the 
detection of a dilated left ovarian vein (LOV) were 100% and 
57%, and for the right ovarian vein (ROV) they were 67% 
and 90% [16]. The high efficiency of US in detecting venal 
reflux was confirmed in the study by Hansrani et al. [17]. 
The authors reported better visibility of pelvic veins in the 
supine position against the semi-standing position (76% 
vs 64%), but better identification of pelvic vein incompe-
tence in the semi-standing position as compared to the 
supine position (76% vs 68%), concluding that a complete 
US evaluation should be performed in both cases, including 
the Valsalva maneuver.
Magnetic resonance imaging (MRI) provides excellent 
pelvic organ imaging and can be utilized for PVI detection. 
Although, it carries the risk of underestimation of the extent 
of the pelvic venous plexus and dilatation of the gonadal 
vein, when performed in dorsal decubitus, several studies 
showed its high sensitivity and specificity reaching 88–100% 
and 38–75%, respectively [2, 18]. A comparable efficacy in 
the assessment of flow velocity and reflux in ovarian veins is 
observed in phase-contrast MRI. However, the time-resolved 
MRI achieved the best efficacy in the imaging of retrograde 
flow in ovarian veins, with an accuracy of 79–85% as com-
pared to conventional venography. Time-resolved imaging 
(TRI) is a specialized 3D contrast-enhanced MR angiographic 
sequence particularly useful for venous imaging and indi-
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cated in cases when a proper diagnosis is dependent on 
the presence and direction of the flow. TRI is effective in the 
detection of non-dilated incompetent ovarian veins and 
dilated but competent ovarian veins and, contrary to con-
ventional venography, reveals possible arteriovenous (AV) 
malformations [19]. Conventional venography is an invasive 
procedure but still constitutes the criterion standard for the 
evaluation of PVI. The diagnostic criteria for PVI include:
1. Dilatation of the uterine and ovarian veins above 5 mm,
2. Presence of retrograde flow in gonadal veins,
3. Stasis of contrast material in pelvic venous plexus, and
4. Opacification of vulvar and thigh varices.
5. Retrograde flow of contrast material through the ute-
ro-ovarian arcade to the opposite side [3]. 
In 2019, a consensus was achieved among UK-based 
interventional radiologists on the optimal imaging strategy 
and definition of important imaging diagnostic features in 
women with PVI. Three consensus statements were defined:
1. Catheter venography is the gold standard investigation 
for the diagnosis of pelvic vein incompetence; 
2. PVI should be defined as “retrograde flow along the 
ovarian or internal iliac veins”
3. Pelvic varices should be defined as “tortuous, often di-
lated, vulval, adnexal, para-uterine veins arising from 
incompetent internal iliac or ovarian veins” [20]. Any-
how, it seems that noninvasive imaging modalities are 
efficient enough to make a proper diagnosis of PVI. In 
summary, the most important imaging feature for the 
diagnosis of PVI is the demonstration of a reflux in one 
or both gonadal veins. Furthermore, the presence of 
a dilated vain which crosses the midline of the uterus 
seems to be the most specific sign of PVI [18].
The differential diagnosis of CPP could be long and 
trying as chronic pain is often the result of a multiple, over-
lapping pain condition, with each contributing to the gen-
eration of pain. Other gynecologic causes of pain in the 
pelvis should include endometriosis with adenomyosis, 
intra-abdominal adhesions, leyomyomas, ovarian remnant 
and residual ovary syndrome, gynecologic malignancies, 
vulvodynia, and dyspareunia. Endometriosis is the most 
common gynecologic cause of CPP and the coexistence 
of other pain syndromes in women with endometriosis 
is higher than in the general population [21]. However, 
the presence and severity of endometriosis does not often 
correlate with symptom severity. Adenomyosis coexists in 
approximately 20% of women with deeply infiltrative endo-
metriosis, however, the relationship between adenomyosis 
and CPP is not fully understood [22]. As it had been shown 
in the Swann study, adenomyosis is frequently identified 
in asymptomatic women with no correlation to pelvic pain 
or abnormal bleeding [23]. The relationship between CPP 
and abdominal adhesions is poorly defined, however, there 
is some evidence that dense adhesions limiting organ mo-
bility may cause pelvic pain [24]. Uterine leiomyomas are 
hardly related to chronic pain, but in one survey CPP was 
reported by 15% of women with fibroids as compared to 
3% by women without fibroids [25]. Ovarian remnant syn-
drome refers to patients who have undergone bilateral 
oophorectomy with ovarian tissue inadvertently left behind, 
while residual ovarian syndrome is related to patients who 
had ovarian conservation and subsequently developed 
pathology. These patients may present cyclic or chronic 
pain with acute flare-ups [26]. Chronic pelvic pain is usually 
a complex condition, thus, the differential diagnosis should 
consider the signs and symptoms of gastrointestinal tract 
dysfunction such as: irritable bowel syndrome, inflammatory 
bowel disease, diverticular colitis, celiac disease; urinary tract 
dysfunction like painful bladder syndrome and recurrent 
urinary tract infections; neurologic causes as nerve injury 
or central sensitization, and musculoskeletal causes, for 
instance, myofascial pelvic pain syndromes or fibromyalgia. 
Depression and other psychiatric comorbidities, opioid de-
pendency, and sexual abuse in the history should also be 
included into clinical investigation.
treAtment
A conservative medical management is suggested by 
several authors as a first-line therapy. The data are limited 
as they come from small randomized trials. Women treated 
with goserelin (3.6 mg per month), medroxyprogesterone 
acetate (30–50 mg per day) or an etonogestrel implant 
reported improved pain and venography scores [27–29].
Patients who do not respond to medical therapy 
can pursue invasive treatment. Embolization is the gold 
standard in the treatment of PVI. Insufficient ovarian veins 
generate a hydrostatic pressure that by embolization could 
be eliminated. Embolization is usually performed on an out-
patient basis. The procedure of embolization of bilateral 
ovarian veins in PCS treatment was introduced by Edwards 
in 1993 [30]. Usually the transfemoral or transjugular ap-
proach is used to achieve gonadal and internal iliac pelvic 
vein access. Transcatheter embolization is performed after 
gonadal venous insufficiency is confirmed by venography. 
For clinical success, scrupulous and complete embolization 
is crucial as there are multiple tributaries of the ovarian veins 
and many collateral veins supporting the flow between 
the contralateral sides of the pelvis. For this purpose, em-
bolization should cover the main ovarian veins with their 
tributaries to the level of the inferior vena cava (IVC) on the 
right side and a level of 3 cm from the renal vein on the left. 
Foamed sclerosants, such as 3% sodium tetradecyl sulfate 
or 5% sodium morrhuate, are often used as adjuncts to coils 
to reduce recanalization and treatment failure. Platinum 
coils are MRI compatible up to 1.5T and go undetected by 
707
Jacek Szymanski et al., Pelvic venous insufficiency
www. journals.viamedica.pl/ginekologia_polska
airport scanners. Usually six coils are sufficient for complete 
embolization but the number can vary from two to ten de-
pending on the clinical situation [6]. Complete occlusion is 
obtained by gradually untwisting the fibered platinum coil 
(FPC) along the vessel [9]. One of the studies showed the 
high effectiveness of the ethylene vinyl alcohol copolymer as 
a sclerosant in the embolization of the ovarian vein [31]. Go-
nadal, vena cava, and internal iliac vein venography should 
be finally performed to confirm the gonadal vein occlusion 
with subsequent selective embolization if residual reflux 
into ovarian, vulvar, or thigh region varices is present [3].
The initial venous puncture and embolization process 
should be performed with reasonable care to avoid seri-
ous complications. Intraoperative complications include: 
hematoma, pneumothorax due to venous puncture, and 
embolization of non-target vessels (coil misplacement). 
Stroke caused by an emboli from coil migration or uncon-
trolled foam has been also reported. Delayed complications 
include an enlarging pneumothorax and coil migration [9].
PVI coexists with leg varicosities in approximately 76%. 
Embolization of incompetent pelvic veins seems to be man-
datory in cases of lower limb varicose veins. In one study, 
embolization led to an improvement of PCS in 91%, and of 
lower limb varicose veins in 51% on its own [32]. Further-
more, there is high incidence of PVI in patients with recurrent 
varices after surgery (REVAS). Monedero et al. [8] reported 
a significant relief of clinical signs and symptoms of pelvic 
and lower extremity venous stasis after the embolization 
of gonadal and hypogastric mainstem and collateral ves-
sels in patients with REVAS and PVI. In contrary, Rabe and 
Panier, based on a literature review, did not find satisfactory 
evidence for the efficiency of ovarian and pelvic vein em-
bolization in the treatment of varicose veins of pelvic origin 
in patients without PCS. The Authors suggest performing 
foam sclerotherapy or phlebectomy in these patients [33].
Abdelsalam reported a 3-year follow-up of 11 patients 
with lower abdominal pain and vulvar varicosities treated 
with unilateral ovarian vein (OV) embolization (6 cases) or 
bilateral OV embolization (5 cases) with the use of spiral 
coils. The procedural success rate was 100%. Post-emboli-
zation pain relief and relief of vulvar varices were encoun-
tered in 70% of patients within 3 months of the procedure; 
however, in 1 patient (10%) the symptoms returned after 
6 months. No significant complications were reported [34]. 
The effectiveness of ovarian vein embolization was con-
firmed in the study by Pyra, in which the clinical success 
was reflected by a decrease in the visual analogue scale 
(VAS) from 8 points at the baseline to 1 point at the 3-month 
follow-up (p < 0.001) [35]. Guirola et al. [36] compared the 
efficacy of vascular plugs (VPs) and FPCs for embolization 
in PVI. They found no statistically significant differences in 
clinical success and subjective improvement concerning 
dyspareunia, dysmenorrhea, urinary urgency, and pelvic 
pain at 1-year follow-up. VPs were associated with decreased 
fluoroscopy time and radiation dose but also with a signifi-
cantly higher cost of therapy.
As revealed by Riding et al. [2], a substantial number of 
studies reporting significantly improved patient outcomes 
following endovascular embolization are of a relatively low 
quality, varying in terms of patient demographics, inclusion 
criteria, various embolization procedures performed, and 
different outcome measures used. There is also heteroge-
neity among the diagnostic criteria for PVI and CPP. The 
approach to the therapy and treatment modalities varies 
among vascular specialists. A survey conducted in the UK 
revealed that 9% of them do not regard pelvic vein reflux as 
a pathological entity and 11% never investigated or treated 
it. Indications for investigation include labial (94%) and 
buttock/upper thigh (70%) varicose veins where 46% used 
MR venography and 16% transvaginal duplex. The treat-
ment modalities include transcatheter coil embolization 
(89%), sclerotherapy via the thigh varicose vein (47%), and 
transcatheter sclerotherapy (26%). Both ovarian veins and 
internal iliac tributaries were treated by 61% of responders, 
while 34% treated only ovarian vein reflux. Such substantial 
variation in the management of pelvic vein reflux requires 
well-designed clinical trials to establish recommendations 
for good clinical practice [37].
Chronic pelvic pain still remains a diagnostic and thera-
peutic challenge. Due to its complexity, it often requires 
a multidisciplinary approach involving gynecologists, vascu-
lar surgeons, and interventional radiologists. PVI, as a cause 
of CPP, seems to be underestimated, although it can be suc-
cessfully treated when properly diagnosed. The therapeutic 
uncertainty raises questions about the number of veins that 
should be closed, the kind of embolization material used, 
and the treatment of vulval varicosities in patients with 
asymptomatic PVI. Well-designed, prospective long-term 
trials are needed to clarify these issues and to establish 
recommended guidelines for clinicians.
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